The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?
Open accessAbstract
The promise of cancer gene therapeutics is hampered by difficulties in the in vivo delivery to the targeted tumor cells, and systemic delivery remains to be the biggest challenge to be overcome. Here, we concentrate on systemic in vivo gene delivery for cancer therapy using nonviral vectors. In this review, we summarize the existing delivery barriers together with the requirements and strategies to overcome these problems. We will also introduce the current progress in the design of nonviral vectors, and briefly discuss their safety issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer
Bardhan, R., Lal, S., Joshi, A., & Halas, N. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200023x · Cited by 917
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
Hatakeyama, H., Akita, H., & Harashima, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.001 · Cited by 645
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Dassie, J. P., Liu, X.-Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 589
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Li, S.-D., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562
Self-citationSheddable Coatings for Long-Circulating Nanoparticles
Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Self-citationCurrent status of pH-sensitive liposomes in drug delivery
Drummond, D. C., Zignani, M., & Leroux, J.-C. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00011-4 · Cited by 477
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Li, J., Chen, Y.-C., Tseng, Y.-C., Mozumdar, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.008 · Cited by 470
Self-citationLipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463
Self-citationSchipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., et al. (2009) · Small · doi:10.1002/smll.200800003 · Cited by 452
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 398
Lee, R. J., & Huang, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8481 · Cited by 397
Self-citationTumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Self-citationA DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA
Wang, K. Y., McCurdy, S., Shea, R. G., Swaminathan, S., & Bolton, P. H. (1993) · Biochemistry · doi:10.1021/bi00059a003 · Cited by 332
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour, L. W. (1992) · PubMed · Cited by 316
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
Polymers for siRNA Delivery: Inspired by Viruses to be Targeted, Dynamic, and Precise
Wagner, E. (2012) · Accounts of Chemical Research · doi:10.1021/ar2002232 · Cited by 308
Li, S.-D., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282
Self-citationPotential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer
Bolhassani, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.006 · Cited by 257
Hatakeyama, H., Ito, E., Akita, H., Oishi, M., Nagasaki, Y., Futaki, S., & Harashima, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.008 · Cited by 254
Chono, S., Li, S.-D., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 238
Self-citationManjappa, A. S., Chaudhari, K. R., Venkataraju, M. P., Dantuluri, P., Nanda, B., Sidda, C., Sawant, K. K., & Ramachandra Murthy, R. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.002 · Cited by 236
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 232
Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma
Huang, S., Li, J., Han, L., Liu, S., Ma, H., Huang, R., & Jiang, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.064 · Cited by 224
Perche, F., Benvegnu, T., Berchel, M., Lebegue, L., Pichon, C., Jaffrès, P.-A., & Midoux, P. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.12.010 · Cited by 218
Hatakeyama, H., Akita, H., Ito, E., Hayashi, Y., Oishi, M., Nagasaki, Y., Danev, R., Nagayama, K., Kaji, N., Kikuchi, H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.045 · Cited by 216
Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions
Elsabahy, M., Nazarali, A., & Foldvari, M. (2011) · Current Drug Delivery · doi:10.2174/156720111795256174 · Cited by 199
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S.-D., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 198
Self-citationZalipsky, S., Qazen, M., Walker, J. A., Mullah, N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198
Cell-specific nuclear import of plasmid DNA
Vacik, J., Dean, B. S., Zimmer, W. E., & Dean, D. A. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300924 · Cited by 197
Solid‐Phase Synthesis of Sequence‐Defined T‐, i‐, and U‐Shape Polymers for pDNA and siRNA Delivery
Schaffert, D., Troiber, C., Salcher, E. E., Fröhlich, T., Martin, I., Badgujar, N., Dohmen, C., Edinger, D., Kläger, R., Maiwald, G., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102165 · Cited by 196
Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy
Chen, Y., Wu, J. J., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2009.291 · Cited by 190
Self-citationMultifunctional envelope-type nano device (MEND) as a non-viral gene delivery system
Kogure, K., Akita, H., Yamada, Y., & Harashima, H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.007 · Cited by 187
In vivo delivery of RNAi with lipid-based nanoparticles
Huang, L., & Liu, Y. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124709 · Cited by 174
Self-citationReversible Covalent Chemistry in Drug Delivery
West, K., & Otto, S. (2005) · Current Drug Discovery Technologies · doi:10.2174/1570163054866882 · Cited by 166
Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic
Wolff, J. A., & Rozema, D. B. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300326 · Cited by 163
Research progress on siRNA delivery with nonviral carriers
Gao, Y., Liu, X., & Li, X. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17040 · Cited by 147
Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles
Suzuki, R., 知子, 滝., Negishi, Y., Utoguchi, N., Sawamura, K., Tanaka, K., Namai, E., Oda, Y., Matsumura, Y., & Maruyama, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.025 · Cited by 145
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
Ni, X., Zhang, Y., Ribas, J., Chowdhury, W. H., Castanares, M. A., Zhang, Z., Laiho, M., DeWeese, T. L., & Lupold, S. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45109 · Cited by 143
Self-citationChumakova, O. V., Liopo, A. V., Андреев, В. Г., Cicenaite, I., Evers, B. M., Chakrabarty, S., Pappas, T. C., & Esenaliev, R. O. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.023 · Cited by 136
Intracellular transduction using cell-penetrating peptides
Sawant, R. R., & Torchilin, V. P. (2009) · Molecular BioSystems · doi:10.1039/b916297f · Cited by 133
pH-Sensitive siRNA Nanovector for Targeted Gene Silencing and Cytotoxic Effect in Cancer Cells
Mok, H., Omid Veiseh, A., Fang, C., Kievit, F. M., Wang, F. Y., Park, J. O., & Zhang, M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100221h · Cited by 128
Targeted Nanoparticles Deliver siRNA to Melanoma
Chen, Y., Bathula, S. R., Yang, Q., & Huang, L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.222 · Cited by 119
Self-citationEndosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA
Sakurai, Y., Hatakeyama, H., Sato, Y., Akita, H., Takayama, K., Kobayashi, S., Futaki, S., & Harashima, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.047 · Cited by 114
Grandinetti, G., Smith, A. E., & Reineke, T. M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200368p · Cited by 110
RNAi-based therapeutic strategies for metabolic disease
Czech, M., Aouadi, M., & Tesz, G. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.57 · Cited by 108
Grandinetti, G., Ingle, N. P., & Reineke, T. M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200078n · Cited by 102
Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding
Fella, C., Walker, G. F., Ogris, M., & Wagner, E. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.05.004 · Cited by 93
RNA interference therapy via functionalized scaffolds
Monaghan, M. G., & Pandit, A. S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.006 · Cited by 85
Negishi, Y., Omata, D., Iijima, H., Takabayashi, Y., Suzuki, K., Endo‐Takahashi, Y., Suzuki, R., Maruyama, K., Nomizu, M., & Aramaki, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900214s · Cited by 84
Different delivery methods—different expression profiles
Federov, Y., KING, A. D., Anderson, E. M., Karpilow, J. M., Ilsley, D. D., Marshall, W., & Khvorova, A. (2005) · Nature Methods · doi:10.1038/nmeth0405-241 · Cited by 78
New insight into clinical development of nucleic acid aptamers.
Esposito, C. L., Catuogno, S., de Franciscis, V., & Cerchia, L. (2011) · PubMed · Cited by 61
Collas, P., & Aleström, P. (1996) · Molecular Reproduction and Development · Cited by 59
Asayama, S., Sudo, M., Nagaoka, S., & Kawakami, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800094b · Cited by 57
Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA delivery
Yin, Q., Gao, Y., Zhang, Z., Zhang, P., & Li, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.014 · Cited by 50
Elastase activated liposomal delivery to nucleated cells
Pak, C. C., Erukulla, R. K., Ahl, P. L., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00256-9 · Cited by 45
Vickers, T. A., Lima, W. F., Wu, H., Nichols, J. G., Linsley, P. S., & Crooke, S. T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp735 · Cited by 37
A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing
Tsai, L.-R., Chen, M., Chien, C., Chen, M.-K., Lin, F.-S., Lin, K. M.-C., Hwu, Y., Yang, C., & Lin, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.059 · Cited by 32
Tumor-targeted RNA-interference: functional non-viral nanovectors.
Pan, X., Thompson, R., Meng, X., Wu, D., & Xu, L. (2011) · PubMed · Cited by 30
Advances and Perspectives in Cell-Specific Aptamers
Sun, W., Du, L., & Li, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049769 · Cited by 23
Cited by
Developing mRNA-vaccine technologies
Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K.-J. (2012) · RNA Biology · doi:10.4161/rna.22269 · Cited by 622
Chen, W.-H., Luo, G.-F., Lei, Q., Hong, S., Qiu, W.-X., Liu, L.-H., Cheng, S.-X., & Zhang, X.-Z. (2017) · ACS Nano · doi:10.1021/acsnano.6b06658 · Cited by 367
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Mastorakos, P., da Silva, A. L., Chisholm, J., Song, E., Choi, W. K., Boyle, M. P., Morales, M. M., Hanes, J., & Suk, J. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502281112 · Cited by 210
Metadata
- Authors
- Zhang, Y., Satterlee, A., & Huang, L.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 20
- Issue
- 7
- Pages
- 1298-1304
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1986842655
- Cited by
- 349
- References
- 69
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
